Wall Street's major averages notice limited moves on Thursday, as the Q4 GDP growth came in weaker than expected, while ...

Nasdaq CEO and chair Adena Friedman joins 'Squawk Box' to discuss the company's quarterly earnings results, state of the IPO ...

Nasdaq ( NDAQ -5.08%), a leading global technology company and stock exchange operator, reported fourth-quarter 2024 earnings ...

As the first earnings cycle of 2025 is ramping up, so are the announcements of new share buyback authorizations. Among these announcements, three big-name U.S. stocks stick out so far, all of which ...

ST. GEORGE, Utah - SkyWest , Inc. (NASDAQ:SKYW) shares jumped 4.3% after the regional airline operator reported ...

United Airlines stock (NASDAQ: UAL) recently reported its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $14.7 billion and adjusted earnings ...

EPS: $0.07 in Q4 vs. $0.00 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...

It is expected to announce its fiscal Q4 earnings results after the market ... of the author and do not necessarily reflect those of Nasdaq, Inc. With headquarters in the heart of Chicago's ...

Let’s see how things have shaped up for LUV this earnings season. Factors Likely to Have Influenced LUV’s Q4 Performance The Zacks Consensus Estimate for LUV’sfourth-quarter 2024 revenues is ...

Telecommunications giant AT&T (NYSE:T) reported fourth-quarter and full-year 2024 earnings on Monday, Jan. 27, that topped analyst consensus estimates. Adjusted earnings per share (EPS) of $0.54 ...

Freight railroad operator CSX (NASDAQ:CSX) reported fourth-quarter and ... fostering resilience to adapt and capitalize on growth potentials. While Q4 was impacted by factors like impairments ...

JNJ beat Q4 earnings and sales estimates, with its Innovative Medicines Unit outperforming expectations. Sales in the unit rose 4.4% YOY to $14.33 billion, led by key drugs such as Darzalex ...